Sign up
Log in
MetLife’s Earnings Beat And 2026 Outlook Might Change The Case For Investing In MetLife (MET)
Share
Listen to the news
  • Recently, MetLife reported that past-quarter adjusted earnings in its Group Benefits segment rose 12% year over year and Retirement and Income Solutions earnings increased 18%, while also confirming the first-quarter 2026 dividend on its Series A floating-rate preferred stock, paid on March 16 to holders of record on February 27.
  • Management now expects fiscal 2026 to deliver double-digit adjusted EPS growth and adjusted return on equity of 15% to 17%, reinforcing analysts’ generally constructive view of MetLife’s earnings power and capital deployment.
  • Next, we’ll examine how MetLife’s outlook for double-digit adjusted EPS growth may influence its existing investment narrative and risk profile.

Capitalize on the AI infrastructure supercycle with our selection of the 33 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.

MetLife Investment Narrative Recap

To own MetLife, you need to be comfortable with a large, global insurer whose earnings are closely tied to underwriting discipline, investment income and capital strength. The latest quarter’s double digit adjusted EPS guidance and segment earnings growth support the near term earnings catalyst, while the key risk around investment margins and asset quality does not appear materially altered by this news.

The confirmation of the first quarter 2026 dividend on MetLife’s Series A floating rate preferred stock underlines the company’s ongoing capital return alongside its EPS and ROE outlook. For investors watching earnings power and balance sheet resilience, this combination of dividend continuity and guidance helps frame how management is positioning the business relative to current analyst expectations.

Yet investors should also weigh how credit risk in commercial mortgage loans could affect capital strength and future earnings resilience if...

Read the full narrative on MetLife (it's free!)

MetLife's narrative projects $83.8 billion revenue and $6.3 billion earnings by 2028.

Uncover how MetLife's forecasts yield a $90.73 fair value, a 32% upside to its current price.

Exploring Other Perspectives

MET 1-Year Stock Price Chart
MET 1-Year Stock Price Chart

Four members of the Simply Wall St Community currently estimate MetLife’s fair value between US$77.46 and US$180.93, illustrating very different views on upside. Set this against management’s double digit adjusted EPS growth outlook and consider how sensitive your own expectations are to interest rate and credit conditions.

Explore 4 other fair value estimates on MetLife - why the stock might be worth over 2x more than the current price!

Reach Your Own Conclusion

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

Ready For A Different Approach?

Right now could be the best entry point. These picks are fresh from our daily scans. Don't delay:

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.